• 011-26907444
  • raghava@iiitd.ac.in

Welcome to Peptide Card of AntiTbPdb

This page displays user query in tabular form.

KWKSFLKTFKSAKKTVLHTALKAISS details
Primary information
ID antitb_1306,
Name20858205
N-Terminal modificationD-(V13K) D1
C-Terminal ModificationKWKSFLKTFKSAKKTVLHTALKAISS
Chemical ModificationAcetylation
Linear/CyclicAmidation
LengthNone
ChiralityLinear
Nature26
SourceL
OriginCationic
SpeciesSynthetic
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis H37Rv
Cell LineMIC = 70.7 μg/mL
Inhibition ConcentrationIn vitro
Sequence2011
CytotoxicityHuman erythrocyte
In vivo ModelNA
Lethal DoseHC50 = 421.5 μg/mL
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1311,
Name20858205
N-Terminal modificationD-(V13K) D1
C-Terminal ModificationKWKSFLKTFKSAKKTVLHTALKAISS
Chemical ModificationAcetylation
Linear/CyclicAmidation
LengthNone
ChiralityLinear
Nature26
SourceL
OriginCationic
SpeciesSynthetic
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis H37Rv multidrug resistant strain vertulo
Cell LineMIC = 57 μg/mL
Inhibition ConcentrationIn vitro
Sequence2011
CytotoxicityHuman erythrocyte
In vivo ModelNA
Lethal DoseHC50 = 7.4 μg/mL
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),